Narayanan, Krithiga
Drug price control in India - an ongoing debate - Economic and Political Weekly - 57(50), Dec, 10, 2022: p.17-20
Price control of life-saving essential medicines is the need of the hour, but the National Pharmaceutical Pricing Authority has allowed a hike of 10% in nearly 800 drugs and devices listed under the National List of Essential Medicines from 1 April 2022 because of the rising input costs. Prices of scheduled drugs are allowed an increase each year acc¬ording to the wholesale price index. Input costs are rising primarily because India is heavily dependent on China for drug imports.- Reproduced
Drug price control in India - an ongoing debate - Economic and Political Weekly - 57(50), Dec, 10, 2022: p.17-20
Price control of life-saving essential medicines is the need of the hour, but the National Pharmaceutical Pricing Authority has allowed a hike of 10% in nearly 800 drugs and devices listed under the National List of Essential Medicines from 1 April 2022 because of the rising input costs. Prices of scheduled drugs are allowed an increase each year acc¬ording to the wholesale price index. Input costs are rising primarily because India is heavily dependent on China for drug imports.- Reproduced